Cancer was one of the Natural sciences good articles, but it has been removed from the list. There are suggestions below for improving the article to meet the good article criteria. Once these issues have been addressed, the article can be renominated. Editors may also seek a reassessment of the decision if they believe there was a mistake.
This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
This article is within the scope of WikiProject Occupational Safety and Health, a collaborative effort to improve the coverage of articles related to occupational safety and health on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Occupational Safety and HealthWikipedia:WikiProject Occupational Safety and HealthTemplate:WikiProject Occupational Safety and HealthOccupational Safety and Health articles
A "looks promising" potential miricle cure for Rectal Cancer (and at least theoretically all and every single other cancers as well) has been discovered in the Clinical trial of the Drug Dostarlimab with 18 patients over a period of 6 months. If confirmed by further trials , it is an uttermost strong contender for the Nobel Prize for Medicine. Currently Cancer is responsible for about 1 in 6 deaths amongst the 7.8 Billion Total Population worldwide , and this is quantum leaps by more the uttermost brilliant breakthrough in the fight by all Professional Doctors and Researchers against this very serious De Facto Death Sentence in most patients. According to Dr. Luis A. Diax III it is "the fist time it has happened in the history of Cancer". As part of the Professional Medical Trial of 18 patients by a team of Doctors and Professional Medical Scientific Researchers , the Drug Dostarlimab was administered to 18 Clinical Trial Rectal Cancer Patients every three weeks for the Clinical Trial Period of six months. At the end of the Six Month Trial Period every single one of the 18 Patients participating in the trial witnessed one of the uttermostly astounding Miricles in the history of Mankind as far as the Medical Profession is concerned , A COMPLETE CURE OF DETECTABLE CANCER , and certainly the most astounding Miricle in the History of Cancer Research.Dostarlimab is a Drug with laboratory produced molecules and act as , once administered to the patient , as substitute antibodies in the human body. 197.184.165.135 (talk) 12:05, 12 June 2022 (UTC)Reply[reply]
Semi-protected edit request on 15 August 2022[edit]
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.
Semi-protected edit request on 15 August 2022 (2)[edit]
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.
In section 4.2, under the header "epigenetics", please consider the following edits:
Please replace the following "Later epigenetic alterations' role was identified.[92]", with "Later a role for epigenetic alterations giving rise to chromatin variants[1] was identified.[92]"
Thank you for considering. Obelista (talk) 20:54, 15 August 2022 (UTC)Reply[reply]
Done, although differently. Zefr (talk) 00:41, 16 August 2022 (UTC)Reply[reply]
This article is currently the subject of a Wiki Education Foundation-supported course assignment, between 11 January 2023 and 5 May 2023. Further details are available on the course page. Student editor(s): Azelenz. Peer reviewers: Hagan2, Ctgibbo.
Wiki Education assignment: 2023SP Communication Research Methods[edit]
This article is currently the subject of a Wiki Education Foundation-supported course assignment, between 15 January 2023 and 11 May 2023. Further details are available on the course page. Student editor(s): Andrewgarcia1973.